In the Pan-European multicenter clinical study FirstPath, INIFY Prostate produced highly accurate, robust and homogenous results at all sites

ContextVision, Digital Pathology, Export, Home, Investor News, News, Patologi 2021-08-31
STOCKHOLM – August 31, 2021 – ContextVision, a medical technology software company specializing in image processing, image analysis and decision support tools for digital pathology, today announced that results from FirstPath – a European multicenter clinical study evaluating performance of INIFY® Prostate in routine clinical practice – were presented at the European Congress of Pathology by […]
Read More

ContextVision: Assessing a Digital Pathology spin-off with a listing on Euronext Growth

ContextVision, Home, Investor News, News 2021-08-26
STOCKHOLM – August 26, 2021 – ContextVision, a medical technology software company specializing in image processing and decision support tools within digital pathology, today announces that the Board of Directors of ContextVision is conducting a review of the company’s structure, and has initiated work assessing a spin-off of the Digital Pathology unit with a goal […]
Read More

ContextVision announces agreement with two renowned US cancer centers for clinical evaluation of INIFY® Prostate

ContextVision, Digital Pathology, Home, Investor News, News 2021-07-06
STOCKHOLM – July 6, 2021 – ContextVision, a medical technology software company specializing in image processing, image analysis and decision support tools for digital pathology, today announced that agreements to conduct a multicenter clinical study of ContextVision’s digital pathology product INIFY® Prostate have been signed with the Ohio State University Comprehensive Cancer Center – Arthur G. […]
Read More

ContextVision Annual General Meeting 2021

ContextVision, Home, Investor News, News 2021-05-05
On the 5th of May 2021, ContextVision held its ordinary Shareholders’ Annual General Meeting in Stockholm. Due to the extraordinary situation that prevails as a result of the covid-19 pandemic the Annual General Meeting was conducted by advance voting (postal voting) with the support of temporary statutory rules (Sections 20 – 22 of the Act […]
Read More

Progress in establishing reference centers within digital pathology

ContextVision, Financial reports, Home, Investor News, News 2021-04-22
ContextVision today reports its first quarter results for 2021. The quarter saw strong and promising progress within digital pathology and the company’s first product, INIFY Prostate Screening. While the ongoing pandemic slowed sales slightly, solid financials – paired with close dialogues with present and prospective clients – provide a positive outlook.
Read More

ContextVision – Invitation to Annual General Meeting 2021

ContextVision, Home, Investor News, News 2021-04-07
STOCKHOLM – April 7, 2021 – ContextVision hereby invites shareholders to the Annual General Meeting on May 5, 2021. Please find attached the invitation including agenda and details on how to register and vote. Please contact: for any questions regarding the AGM. For inquiries, please contact CFO Ann-Charlotte LinderothE-mail: About ContextVisionContextVision is a […]
Read More